Essentials of Systemic Cancer Therapies for the Oncology Nurse

---

LIVE

Wednesday, December 15, 2021, 8:00 AM - Tuesday, December 21, 2021, 4:30 PM, Online, Houston, TX


General Attendance (7.49 hours), General Attendance (7.55 hours), ANCC Contact Hour(s) (7.55 hours), ANCC Contact Hour(s) (7.49 hours), Pharmacotherapeutics (2.88 hours), Pharmacotherapeutics (2.52 hours)

Enable oncology nurses to apply informational resources and guidelines for knowledgeable and safe administration of systemic cancer therapies and apply evidence based nursing care interventions (including patient education), to prevent, minimize, and/or manage associated adverse effects. Day 1 will be virtual (Zoom) and Day 2 will be on-site R11.1400 (Hickey Auditorium) Requirements for Successful Completion of Program: • Register • Attend entire learning activity • Successfully pass post test with minimal score of 80% • Complete evaluation within 7 days

1. State principles guiding systemic cancer therapies (standard regimens and clinical trials) and response, based upon a basic understanding of carcinogenesis.
2. Address the continuum of care during the cancer journey for various patient populations
3. Discuss phases of clinical trials and the nurse’s role.
4. Discuss how systemic treatments for cancer work (chemotherapy, hormone therapy, molecular targeted therapy and immunotherapy), including principles guiding cancer therapy and effects on cell proliferation.
5. Describe classifications and associated side effects of chemotherapy, hormone therapy, molecular targeted therapy and immunotherapy.
6. Articulate nursing standards and available resources that address nursing practice for safe administration of systemic cancer therapies, including patient education.
7. Discuss the process of safe administratin of antineoplastic agents, including accurate calculation of body surface area (BSA) and dosing
8. Describe safety implications for the various administration routes of systemic cancer therapies.
9. Describe safe handling practices when managing hazardous drugs, including patient management, personal protective equipment (PPE) and spill management.
10. Identify prevention, recognition and management measures of local site reactions associated with vesicant extravasation, irritation and flare reactions.
11. Identify prevention, recognition and management of systemic reactions associated with drug administration including hypersensitivity, anaphylaxis and cytokine-release syndrome.
12. Identify critical assessment parameters and nursing interventions for myelosuppression caused by systemic cancer therapies.
13. Describe incidence, risk factors, assessment and interventions for management of systemic cancer therapy induced nausea and vomiting.
14. Discuss potential sexual and reproductive concerns for patients who receive cancer treatments, including assessment, communication and management strategies.
15. Discuss ethical and legal issues that nurses may face when administering systemic cancer therapies, incorporating standards, laws, and position statements as guides.
16. Apply principles, resources and standards to describe steps in pre-treatment preparation and verification, including review of treatment plans, orders, dose calculations and patient education in discussion exemplars.
17. Apply principles, resources, standards and evidence-based nursing care interventions to prevent, minimize or manage side effects and toxicities of combination systemic cancer therapies across the cancer care continuum.

This is a 2 day program that will award Nursing Continuing Professional Development (NCPD) credit upon successful completion of post-test (open book) with minimum score of 80%. 

Please note Day 1 has been converted to a virtual format using Zoom. 

You must attend Day 2 on site.

Those who register will receive an email with educational materials that can be accessed electronically.

Zoom Link:

https://mdacc.zoom.us/j/84321140237?pwd=cEZXQ1FwMlZqM1J0UDlrbzJneHZHQT09 

 

 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.